Here are five things to know:
1. The brokers gave Mazor stock at 1.86 rating.
2. The seven brokers rate Mazor stock as “buy.”
3. There are three equities research analysts give the stock a “hold” and four with a “strong buy.”
4. The company’s rating score dropped 11.4 percent in 90 days.
5. The price target is $15.88, according to the brokers.
6. The brokers predict the company will post a $0.22 EPS for this quarter.
More articles on orthopedic devices:
Shoulder reconstruction device market to see rapid growth—With DePuy Synthes at the helm
New NuVasive CEO Gregory Lucier buys 34k shares—5 key notes
LESS Institute gets $30M senior credit facility—5 key notes
